The FDA has just approved the anitpsychotic drug, Fanapt (iloperidone) for adults with schizophrenia.
The drug, iloperidone, has a long history of failure. http://en.wikipedia.org/wiki/Iloperidone : Continue reading →
Novartis
AHRP Letter to Harvard Re: Dr. Biederman’s Research
AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman’s publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies. Continue reading →
All Bias, All BULL–Psychiatry Deception Re: ADHD Drugs Benefits_WashPost
ADHD published reports have been carefully crafted to declare pro-drug "conclusions"–but those conclusions are belied by the actual evidence about the long-term effects of ADHD drugs on children’s health. Continue reading →
Two Cases of Massive Fraud–Anesthesiology–Psychiatry
Two major cases of medical fraud have undermined patient safety and the integrity of the medico-scientific literature: But how each specialty responded is a study in contrast. Continue reading →
Marcia Angell: Drug Co & Doctors: A Story of Corruption
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD Continue reading →
Letter of Complaint Re: FDA Double Agent
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels. Continue reading →
Letter of Complaint to FDA Commissioner, 2007
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion. Continue reading →
Non-profit Fronts for Drug Industry_Boston Globe
These paid lobbying efforts on behalf of industry are carried out under the pretext of advocacy in the public interest.
Continue reading →
Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa
The deceptive marketing of antipsychotic drugs has prompted new advocacy group to launch "The Just Say "Know" to Prescription Drugs Campaign." Its goal is to get one million people to stop and reevaluate the medications they are taking. Continue reading →
Assaultive Prescribing of Psych Drugs for Children
Australian psychiatrist: "Does anyone else see tardive dysmentia after atypicalantipsychotics?"
U.S. Doctors are prescribing the antidepressant, Effexor (150mg) for infants under age one!
Psychiatric Drug Mix for Young On Shaky Grounds_ NYTimes
The lead story in The New York Times on Thanksgiving day (below) acknowledged several facts demonstrating that children are the victims of major medical malpractice:
Leading Antipsychotic Drugs Come Under New Scrutiny – NYT
Leading Antipsychotic Drugs Come Under New Scrutiny – NYT Tuesday, May 20, 2003 A front page article in The New York Times reveals that the pillars of American psychiatry–including Dr. Jeffrey Lieberman, Dr. John Kane, Dr. William Carpenter–are acknowledging that evidence is . . . Continue reading →